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National implementation of reperfusion
for acute ischaemic stroke in England:
How should services be configured? A
modelling study
Michael Allen1, Kerry Pearn1, Gary A Ford2, Phil White3, Anthony G Rudd4,
Peter McMeekin5, Ken Stein1 and Martin James1,6
Abstract
Objectives: To guide policy when planning thrombolysis (IVT) and thrombectomy (MT) services for acute stroke in
England, focussing on the choice between ‘mothership’ (direct conveyance to an MT centre) and ‘drip-and-ship’ (secondary
transfer) provision and the impact of bypassing local acute stroke centres.
Design: Outcome-based modelling study.
Setting: 107 acute stroke centres in England, 24 of which provide IVT and MT (IVT/MT centres) and 83 provide only IVT
(IVT-only units).
Participants: 242,874 emergency admissions with acute stroke over 3 years (2015–2017).
Intervention: Reperfusion delivered by drip-and-ship, mothership or ‘hybrid’ models; impact of additional travel time to
directly access an IVT/MT centre by bypassing a more local IVT-only unit; effect of pre-hospital selection for large artery
occlusion (LAO).
Main outcome measures: Population benefit from reperfusion, time to IVT and MT, admission numbers to IVT-only
units and IVT/MT centres.
Results:Without pre-hospital selection for LAO, 94% of the population of England live in areas where the greatest clinical
benefit, assuming unknown patient status, accrues from direct conveyance to an IVT/MT centre. However, this policy
produces unsustainable admission numbers at these centres, with 78 out of 83 IVT-only units receiving fewer than 300
admissions per year (compared to 3 with drip-and-ship). Implementing a maximum permitted additional travel time to
bypass an IVT-only unit, using a pre-hospital test for LAO, and selecting patients based on stroke onset time, all help to
mitigate the destabilising effect but there is still some significant disruption to admission numbers, and improved selection of
patients suitable for MT selectively reduces the number of patients who would receive IVT at IVT-only centres, challenging
the sustainability of IVT expertise in IVT-only centres.
Conclusions: Implementation of reperfusion for acute stroke based solely on achieving the maximum population benefit
potentially leads to destabilisation of the emergency stroke care system. Careful planning is required to create a sustainable
system, and modelling may be used to help planners maximise benefit from reperfusion while creating a sustainable
emergency stroke care system.
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Introduction
In England, about 80,000 people are hospitalised each year
with acute stroke,1,2 and over half of these people are left with
long-term disability at great cost to individuals and society.3
Disability and institutionalisation after ischaemic stroke are
significantly reduced by reperfusion treatments – intravenous
thrombolysis (IVT)4 and mechanical thrombectomy (MT).5
IVT is a treatment that may be considered for all potentially
disabling ischaemic strokes and in England and Wales about
40% of emergency stroke patients have known stroke onset
and arrive within 4 h of onset.6 MT may be considered for all
large artery occlusions (LAO), which are present in up to 40%
of all acute ischaemic strokes.7
In 2019–2020, in the UK, these treatments were given to
11.7% and 1.8% of patients with acute stroke, respectively.2
The 2019NHS England Long Term Plan8 set out the ambition
that, by 2025, acute stroke units will deliver IVT to about 20%
of patients, and MT to about 10%. To achieve such increases
in reperfusion, the NHS England Long Term Plan ac-
knowledges the need for the centralisation of hyperacute
stroke care into fewer well-equipped and staffed hospitals,
noting that metropolitan areas that have recently centralised
stroke care have achieved improved outcomes.9,10
Two principal models for the provision of reperfusion are
generally considered: the so-called mothership, where re-
gional centres (sometimes referred to as comprehensive stroke
centres) provide IVT and MT for all eligible suspected stroke
patients, with ambulances bypassing local acute services; and
drip-and-ship, where IVT is provided at smaller local units
(sometimes referred to as acute stroke centres), followed by
secondary transfer of selected patients to regional centres for
MT. Currently, drip-and-ship is the predominant and com-
missioned model of provision in the UK. Reconfiguring
hyperacute stroke services to a more centralised mothership
model could increase direct access to MT for the eligible
minority, but at the expense of increased travel times and
delayed IVT for many patients; it could also substantially
increase admissions to the regional MT centres, many of
whom would be ineligible for reperfusion. Modelling and
simulation has been suggested as being particularly useful in
planning of stroke care for being able to generalise outside of
local clinical studies.11 We therefore set out to examine the
impact of the reperfusion ambitions in theNHSEngland Long
Term Plan for stroke on population disability, and tomodel the
optimal organisation of hyperacute stroke provision necessary
to achieve these ambitions in a sustainable way.
Method
Location of thrombolysis and thrombectomy centres
The location of thrombolysis centres was taken as the 107
hyperacute stroke units in England providing thrombolysis
in 2019.2 Within this number, the location of IVT/MT
centres, in our base case model, was taken as the 24 neu-
roscience centres in England which are either providing or
planning to provide MT2 (in a recent survey of stroke units
across all the UK, 24 out of 28 planned MT centres were
operational).12
Admission numbers and travel times for patients
Patients are located to one of 32,833 Lower Super Output
Areas (LSOA) in England. Hospital admissions for stroke in
England per LSOA for 3 years 2015–2017 were obtained
from NHS Hospital Episodes Statistics, including 242,874
patients coded with an emergency admission of confirmed
ischaemic or haemorrhagic stroke (primary diagnosis ICD-
10 I61, I63, I64). When predicting the number of MT
procedures, we have usually assumed that the proportion of
confirmed stroke patients eligible for MT in the UK is 10%
of all stroke, as previously estimated,13 and we use the NHS
target for 20% IVT.8 In England and Wales, 88% of hos-
pitalised stroke patients have an ischaemic stroke.14 Current
use of IVT is 11% of all confirmed stroke patients across all
of England, but this ranges between hospitals from 4 to
22%.14 As MT is currently being established, there are no
steady-state figures yet for the use of MT in England. We
model based on 107 active IVT centres in 2019, and 24
planned MT centres.
Travel times were estimated from all LSOA to all
hospitals using Microsoft MapPoint. In a ‘drip and ship’
model, where an inter-hospital transfer may be required for
MT, we assumed a net delay in MT of 60 min + inter-
hospital transfer time (obtained from MapPoint).
Clinical outcome
Clinical outcome from reperfusion is quantified in terms of a
disability-free outcome 3 months after stroke (a modified
Rankin Scale score of 0–1/6 describes either no or only
minor non-disabling symptoms).15 We have published the
detailed method and code used to estimate outcomes.16 This
method is a development of the method of Holodinsky
et al,17 and incorporates the known decay of effectiveness of
IVT4 and MT18 over time.
For those patients with the prospect of treatment we
assume it takes 60 min from stroke onset to the ambulance
leaving the scene. Time to IVT is therefore 60 min +
ambulance travel time + door-to-needle time (D2N). D2N
times for IVT in the model are set to a standardised 40 min
across all hospitals. For patients who attend an IVT/MT
centre as their first admitting hospital, time to MT is given
by 60 min + ambulance travel time + door-to-puncture time
(D2P), where D2P for MT in the model are standardised to
90 min across all hospitals.
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If a patient first attends a unit which does not provide
MT, the time to MT incurs a further net delay and added
inter-hospital travel time. The net delay used may be shorter
than the actual door-in to door-out time at the first admitting
hospital, as some process steps have already been completed
on arrival at the MT centre. Previously, in a large clinical
trial it was shown that patients receiving MT after transfer
were treated 110 min later than patients admitted directly,
35 min of which was attributable to inter-hospital travel
time, suggesting a net delay of 75 min + travel time.19 In our
modelling we have anticipated some improvement over
these historical results and have assumed a 60 min net delay
in addition to the inter-hospital transfer travel time.
Pre-hospital selection
In recent years, several methods for ambulance paramedics
to select patients with LAO as potential candidates for MT
have been developed.20 We have used the performance of
one of the most widely studied, the RACE pre-hospital
clinical diagnostic for LAO,21 to assess the potential impact
of selection of patients most likely to benefit from direct
transport to an IVT/MT centre, bypassing any nearer IVT-
only centre. We model the effects of the RACE test based on
published results,21 in which 32% of all stroke were large
vessel occlusions, and a RACE scale ≥5 (henceforth re-
ferred to as a positive RACE test) had sensitivity 0.85,
specificity 0.68, positive predictive value 0.42, and negative
predictive value 0.94 for detecting LAO.
Varying number and location of
thrombectomy centres
For selecting locations of IVT/MTcentres (in addition to the
current 24 neuroscience centres) we have used a genetic
algorithm as previously described.22 Briefly, we used a be-
spoke genetic algorithm based on NSGA-II.23 Genetic al-
gorithms maintain a population of solutions. These solutions
go through a series of generations where new solutions are
formed by hybridising two existing solutions (with occasional
random mutation). In each generation, the best solutions are
kept. For selection of best solutions, we used a pareto-based
method whereby, when there are multiple objectives, gen-
erated solutions are eliminated if another solution is equally as
good in all optimisation parameters and is better in at least one
parameter. The selected configurations were based on a range
of optimisation parameters which seek to minimise travel
times and to control admission numbers. National guidelines
recommend a minimum number of admissions to an acute
stroke unit, providing IVT, of 600 patients per year,24 coupled
to the recommendation that travel time to hyperacute stroke
care should be ideally 30 min or less, and no more than
60 min.25 A further competing priority is the minimum
number of MT procedures to be performed by any given unit
to maintain institutional expertise. In order to maintain the
procedural skills of interventional teams and yet have suffi-
cient specialists to staff a rota, we have used a minimum
threshold of 150 MT procedures per year for an IVT/MT
centre.26
Results
Benefit of IVT and MT – Drip and ship
We estimated net clinical benefit of a drip-and-ship model of
care, where all patients are assumed to travel to their closest
acute stroke unit (providing at least IVT) first, and travel
onwards to their nearest IVT/MTcentre if necessary. If current
IVT rates (which average 11%, but range from 4 to 22%) are
used, then the clinical benefit without and with 24/7 MTat 24
current neuroscience centres would be 10.9 and 18.0 addi-
tional disability-free outcomes/1000 admissions (we assume
the rate of MT is half that of IVT). If uniform 20% IVT and
10% MT rates were achieved then clinical benefit without
and with 24/7 MT at 24 neuroscience centres would be 18.9
and 31.1 additional disability-free outcomes/1000 admissions.
Figure 1 shows the geographical variation in clinical benefit
with these scenarios. First hospital admissions in this model
range from 259 to 1964. If patients attend their closest unit
first, 27% directly attend an IVT/MT centre first.
The rest of the analysis presented assumes uniform 20%
IVT and 10% MT rates.
Benefit of IVT and MT – Mothership
If all patients travelled to their nearest IVT/MT centres and
bypassed a more local IVT-only unit, the delay in IVT and
the effect on clinical outcome is shown in Figure 2. The net
clinical benefit would be an additional 33.5 disability-free
outcomes/1000 admissions. The mothership model there-
fore gives a modest net improvement in outcome over drip-
and-ship; though importantly individual regions may have a
poorer or better predicted outcome with a mothership model
(ranging from a reduction of 4.0, to an increase of 13.8
additional disability-free outcomes/1000 admissions, with
5th and 95th percentiles of 0.0 and 6.0 increase). 66% of
LSOA have an improvement of at least two additional
disability-free outcomes/1000 admissions with a mother-
ship model. First hospital admissions in this model range
from 1228 to 6,183, with 22 out of 24 IVT/MT centres
receiving more than 2000 patients per year.
Destination based on most likely good outcome
Instead of all patients being conveyed to their closest acute
stroke unit as in the drip-and-ship model, or all patients
travelling directly to their nearest IVT/MT centre as in the
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mothership model, it is possible to make a patient-specific
decision by using a prediction, in the absence of any di-
agnostic test for LAO, as to whether disability outcome is
improved by bypassing a more local IVT-only unit and
travelling further to directly attend an IVT/MTcentre. In this
model, net clinical benefit is predicted to increase to 33.6
additional disability-free outcomes/1000 admissions, a
marginal improvement over an exclusive mothership model.
Figure 3 shows the effect that this has on the catchment
areas of IVT-only units and IVT/MT centres. Compared to
the drip-and-ship model, the travel time to the first admitting
stroke unit is, on average, increased from 19 to 34 min, but
travel time to an IVT/MT centre is reduced from 94 to
42 min. Such a strategy causes significant disruption to
admission numbers. Compared with the drip-and-ship
model, the proportion of patients directly attending an
Figure 1. Geographical variation in clinical benefit (additional good outcomes / 1,000 admissions). a) IVT provided at 107 stroke units,
with IVT rates for units taken from 2018 to 19 SSNAP report.6 b) IVT provided at 107 stroke units, with 20% IVT at all units. c) IVT
provided at 107 stroke units, and MT also provided at the 24 neuroscience centres, with IVT rates for units taken from 2018 to 19
SSNAP report.6 d) IVT provided at 107 stroke units, and MT also provided at the 24 neuroscience centres, with 20% IVT at all units.
Circles show IVT-only units, stars show MT centres, with 10% patients receiving MT.
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Figure 2. The effect of implementing a mothership model, where all patients bypass their more local IVT-only unit (circles) to directly
attend one of the 24 MT centres (stars). Maps show delay in receiving IVT (left panel) and net change in the clinical benefit of
reperfusion (right panel).
Figure 3. Catchment areas for either MT centres (stars) or IVT-only units (circles) if decision on conveyance to first stroke unit is made
by either closest unit (left panel) or the destination that gives the highest probability of a good outcome (without any pre-hospital
diagnostic; right panel). The model has 24 MT centres at the current neuroscience centres and 83 IVT-only units at the remaining current
acute stroke centres.
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IVT/MT centre rises from 27% to 94%, and average first
admissions to an IVT/MT centre rises from 919 to 3187 (a
246% fold increase compared with all patients attending
closest unit first), with the largest centre increasing from
1964 to 5578. Average first admissions to IVT-only units
fall from 710 to 43 (a 94% reduction compared with all
patients attending closest unit first), with 78 out of 83 IVT-
only units receiving fewer than 300 admissions per year
(compared to 3 with drip-and-ship).
This effect on admissions may be mitigated by only
choosing patients for transport to a MT-capable centre only
if they have a non-mild stroke (NIHSS > 5), have a known
stroke onset time, and would expect to arrive at hospital
within about 6 h of known stroke onset. National registry
England and Wales6 show that 24.5% of emergency stroke
admissions met these three criteria (these patients accounted
for 73% of patients who received thrombolysis). If only
these patients could be identified and selected for bypass of
their local IVT unit, then the proportion of patients directly
attending an IVT/MT centre would increase from 27% to
44%. Average first admissions to an IVT/MT centre would
be 1474 (a 60% increase compared with all patients at-
tending closest unit first), with the largest centre having
2725 admissions. Average first admissions to IVT-only
units would be 549 (a 23% reduction compared with all
patients attending closest unit first), with 6 IVT-only units
receiving fewer than 300 admissions per year.
Destination based on maximum additional
travel time
So far we have examined the effect of bypassing a nearer
IVT-only centre in order to directly attend an IVT/MTcentre
for all patients (mothership model), and just for those for
whom it is expected that bypass will confer a better clinical
outcome.Alternatively, we can assess the impact of allowing a
maximum additional travel time in order for a patient to travel
directly to an IVT/MT centre. In previous studies, we have
introduced the concept of ambulance bias, defined as the
additional time that an ambulance crew is willing to travel in
order to convey a patient directly to an IVT/MT centre. As
ambulance bias increases, a number of effects are observed
(Figure 4): average time to IVT is increased, average time to
MT is reduced, net clinical outcome is improved, admissions
to IVT-only units fall and admissions to IVT/MT centres
increase. For example, if ambulance crews are willing to
travel 15 min further in order to directly attend an IVT/MT
centre, the net benefit of reperfusion treatment increases from
31.1 to 32.3 additional good outcomes per 1000 admissions.
However, the proportion of all stroke patients admitted di-
rectly to an IVT/MTcentre would increase from 27% to 52%.
The number of units with fewer than 300 first admissions per
year increases from three to 18, while the number of units with
fewer than 600 first admissions per year increases from 39 to
64 (out of 83 IVT-only units in total). At the same time, the
number of units with more than 2000 first admissions increase
from zero to eight.
This effect on admissions may again be mitigated by
selecting those patients with a known stroke onset time,
with arrival at hospital expected within 6 h from onset, and
with a NIHSS > 5. With 15 min allowable extra time to
reach the MT-capable centre the proportion of all stroke
patients admitted directly to an IVT/MT centre would be
33%. Average first admissions to an IVT/MT centre would
be 1127 (a 23% increase compared with all patients at-
tending closest unit first), with the largest centre having
2574 admissions. Average first admissions to IVT-only
units would be 649 (a 9% reduction compared with all
patients attending closest unit first), with 4 IVT-only units
receiving fewer than 300 admissions per year.
Pre-hospital selection for large artery occlusion
Applying the RACE pre-hospital clinical diagnostic test for
LAO, with all ‘RACE-positive’ patients taken directly to an
IVT/MT centre, increases the number of additional
disability-free outcomes from 31.1 to 33.4 per 1000 ad-
missions. However, the proportion of all stroke patients
admitted directly to an IVT/MT centre would increase from
27% to 62%. The number of units with fewer than 300 first
admissions per year increases from three to 30, while the
number of units with fewer than 600 first admissions per
year increases from 39 to 74 (out of 83 IVT-only units in
total). At the same time, the number of units with more than
2000 admissions increases from zero to eleven.
The effect on admissions may be mitigated further by
selecting those patients with a known stroke onset time,
with arrival at hospital expected within 6 h from onset.
Assuming the proportion of patients with known stroke
onset time, and their expected arrival time at hospital, are
similar to patients with NIHSS of greater than 5, the pro-
portion of all stroke patients admitted directly to an IVT/MT
centre would be 47%. Average first admissions to an IVT/
MT centre would be 1571 (a 71% increase compared with
all patients attending closest unit first), with the largest
centre having 2791 admissions. Average first admissions to
IVT-only units would be 521 (a 27% reduction compared
with all patients attending closest unit first), with 8 IVT-only
units receiving fewer than 300 admissions per year.
Increasing the number of thrombectomy units
Our genetic algorithm identified the optimal locations of
additional IVT/MT centres, in order to maximise access to
MTwhile also limiting maximum admission numbers to all
units (Figure 5). As the number of units providing both IVT
and MT increases, time to MT reduces and the net clinical
benefit of reperfusion treatment increases from 31.1 to 36.2
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additional good outcomes per 1000 admissions with all 107
units providing both IVT and MT. However, beyond about
30 IVT/MTcentres, the capacity to maintain 150 procedures
per year at each centre markedly reduces. If all IVT/MT
centres are required to perform at least 150 MT procedures
per year the maximum clinical benefit, achieved with 29
IVT/MT centres, is 31.5 additional disability-free outcomes
per 1000 admissions.
Discussion
Summary of findings and comparison to
previous modelling
There have been a number of modelling studies on the
relative benefits of mothership versus drip-and-ship.17,27–30
Our work applies previously described outcome-based
modelling methods17 to a population of 52.5 million in
England. Previous studies on outcome focus on using
modelling to decide where best to take patients—to a closer
IVT-only unit or a more distant MT-capable centre, though
Saraj et al.31 also compared a bypass strategy with converting
up to 20% of existing IVT-only units in the US toMT-capable
units, and found that a 15 min bypass strategy (allowing an
extra 15 min journey time to directly access MT) increased
access to MT in the US more than converting 20% of existing
IVT-only units to also provide MT. Our work uses modelling
to examine outcomes, but also to examine the expected impact
on acute stroke units with differing organisational strategies.
While an individual patient-centred analysis of outcomes may
favour one particular model, consideration must also be given
to unintended potential destabilising effects of the strategies.
Studies have looked at ways of managing the demand at MT
centres,32,33 but less consideration has been given to the
potential loss of experience and expertise in administering
alteplase in IVT-only centres. Overwhelming MT-capable
Figure 4. The effect of ambulance bias on travel time to IVT and MT (top left panel), clinical outcome (top right panel), first admission
numbers to IVT-only units (bottom left panel) and first admission numbers to MT centres (bottom left panel). Ambulance bias is
measured as the additional travel time an ambulance crew will allow to go directly to a MT centre instead of a closer IVT-only unit.
Boxplots showmedian (mid-way line), interquartile range (box) and range (whiskers) for individual units. The model has 24 MT centres at
the current neuroscience centres and 83 IVT-only units at the remaining current acute stroke centres.
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centres or depleting IVT-only centres of experience may both
destabilise emergency stroke services leading ultimately to a
sub-optimal solution for the patient population overall.
Our modelling is based on England, but the results are
similar to those described in other countries and contexts.
For example, Schlemm et al.30 found that patient outcomes
across Germany would best be served by a mothership model
of care across the country, and studies by Holodinsky
et al.34,35 have shown that retaining IVT-only site adds value
only if transport times to MT-capable centres are long and if
the IVT-only centre can reach ‘ideal’ door-to-treatment times
of 30 min or less. Minimising door-in-door-out times at IVT-
only centres is essential to good performance of a drip-and-
ship model of care.36 Similar to those studies, we have found
that the population benefit from reperfusion is maximised
when the proportion of units that are MT-capable is highest.
Put another way, the closer the ultimate national configuration
of acute stroke units is to a full mothership model, the greater
the benefits achievable from reperfusion as a whole. This can
be achieved either by reducing the number of IVT-only units,
or by increasing the number of IVT/MT centres. There are
however barriers to increasing the number of IVT/MTcentres
(such as capital cost, workforce and the time taken to establish
infrastructure). While maximum patient benefit may be
achieved by sending most people to the existing/planned 24
MT-capable centres, without effective pre-hospital selection
this would produce admission numbers that are unsustainable.
Local IVT-only centres are therefore required to manage
demand at MT-capable centres and create a sustainable
emergency stroke system.
Ambulance bias or ‘bypass’
Although we have identified that a hybrid model of IVT-
only units and IVT/MT centres is preferable to create a
sustainable system, we have also identified some important
factors that would destabilise any hybrid system. Principal
among these is the natural inclination for ambulance
paramedics to travel a little further in order to improve the
chances of reperfusion treatment for the individual patient
under their care, which we have called ‘ambulance bias’.
This phenomenon is well recognised anecdotally, with some
IVT/MT centres reporting ambulances travelling up to
30 min further to deliver their patient to a MT-capable site
(C Roffe, personal communication). This strategy, also
known as ‘bypass’, has been recommended in US and
European guidelines for suspected LAO.37–39 This has the
net effect of converting any hybrid system towards a de
facto mothership model, with a pronounced increase in the
proportion of patients conveyed directly to an IVT/MT
centre, and a corresponding reduction in admissions to
IVT-only units, effectively negating the mitigating effect of
having IVT-only units. These considerations of institutional
viability (at either end of the scale for stroke admissions)
have not featured in the reasoning behind other analyses
based on additional transport time and bypass.40
Figure 5. The effect of converting IVT-only units to MT centres. The charts show effect on travel time to a MT centre (left panel), the
percentage of patients meeting MT admission/activity targets (middle panel), and the clinical benefit from reperfusion (right panel). The
base case model has 24 MT centres at the current neuroscience centres and 83 IVT-only units at the remaining current acute stroke
centres.
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Pre-hospital patient selection to mitigate the
destabilising effects of bypass
In our study we have first modelled a system where all
patients will follow the drip-and-ship or mothership para-
digm before examining methods of mitigating the signifi-
cant shifts in admission numbers. In reality, many patients
unsuitable for IVT or MT will not need transfer to a MT-
capable centre. In England, 25% of patients with acute
stroke have a NIHSS score of six or more and a known
stroke onset time of less than 6 h before arrival at hospital,6
and so it may be considered that this subset of patients is the
great majority of those eligible for direct transfer to a MT-
capable centre. However, the proportion of patients who
may be considered for MT has been expanded by the use of
advanced imaging to include those with unknown onset
time,41 onset-to-arrival times of up to 24 h,42 and milder
strokes with a large radiographic perfusion deficit who are at
higher risk of deterioration.43 If only those patients with a
known stroke onset time more than 12 h ago are regarded as
unsuitable for bypass, this would constitute just 13% of
stroke patients.6 The proportion of patients that may be
ruled out for direct transfer to a MT-capable centre is
therefore likely to lie somewhere between 13% and 75%
depending on the criteria and pre-hospital clinical diag-
nostic tests applied.
The pre-hospital selection of patients for bypass using
clinical diagnostic tests for LAO is aimed at identifying
those patients most suitable for MT. From among many
such tests, we have used the RACE21 to exemplify pre-
hospital selection because there is a good level of published
detail available and it has also recently been shown to be the
best performing among a range of 8 similar pre-hospital
clinical scales,44 but other triage scales have been im-
plemented, such as LAMS.45 Though RACE improves
selection of LAO patients, we found applying RACE still
has the potential to destabilise the current organisation of
care through its low specificity; furthermore the latest trial
data suggest that the widespread use of such pre-hospital
selection does not confer the anticipated benefits in terms
of improved outcomes from bypass and earlier treatment
with MT.40 More sophisticated pre-hospital pathways,
such as supporting paramedics with centralised triage33 or
advances in technology, such as use of biomarkers46 or
ultrasound devices47 for detecting LAO, may be neces-
sary to achieve the requisite balance of sensitivity and
specificity. Selection of patients eligible for MT will al-
ways selectively divert patients who are more likely to
also receive IVT. For example, while 25% of patients may
be selected for direct transfer to a MT-capable centre
using the three criteria of a known stroke onset time,
arrival at hospital within 6 h of known stroke onset and a
NIHSS of >5, these patients account for 73% of throm-
bolysis use.6
Alternative strategies
Other strategies for the widespread delivery of endovascular
stroke therapy have been proposed, including mobile in-
terventionist teams48,49 who travel to the patient’s nearest
admitting hospital. We have not modelled these and restricted
our study to those solutions that are under consideration
across England and are likely to be implementable at a na-
tional scale within existing NHS infrastructure. In particular,
the infrastructure costs of developing a much larger number of
sites capable of intracranial endovascular interventions are
prohibitive. For the UK, with its relatively low proportion of
MT-capable sites (22% of all acutely admitting sites), the
choice essentially lies between drip-and-ship or mothership
models of care, or a combination of the two. Similarly, we
have assumed patients are transferred by road, rather than by
other means such as helicopter, although this may offer a
feasible and cost-effective option for a few more remote
populations if it reduces travel time by more than 60 min.50
Model assumptions
We have based our model on assumptions regarding a
reasonably achievable level of both IVT and MT, at 20%
and 10% of all admitted stroke cases respectively.8 For IVT,
these rates of treatment are observed in many regions and
countries elsewhere in Europe51,52 but significantly more
progress is needed in the UK to achieve this target as IVT
treatment has remained unchanged at 11–12% over the last
7 years, with persisting five-fold variation between hospitals
in use of thrombolysis.2 Our modelling assumes the MT is
well established in the designated MT centres, and so
provides a ‘final steady state’ view of the potential clinical
benefit and admission numbers to different unit types.
Currently across the UK MT is known to be established at
24 of 28 planned MT-capable centres12 though still only a
minority of sites are presently operating 24/7. It may
therefore be some time yet before the greater levels of
population benefit identified in our study are realised in
practice.
When modelling the effect of drip-and-ship or mother
ship models, we assume that the only difference between
these models is time to treatment; we assume that all units
behave similarly and that there is no deleterious effect of
transport other than it’s effect on time to treatment. These
simplifications allow us to isolate those effects that are due
to changes in times to treatment for IVT and MT. Local
planning may need to take into account other factors,
particularly thrombolysis use and speed at local hospitals.
Studies of inter-hospital transfer for MT have concluded the
general safety of transfer, though the most severe stroke
patients being transferred large distances may benefit from
the presence of a physician.53,54 The potential adverse impacts
from large numbers of patients ineligible for reperfusion being
Allen et al. 9
displaced to a more remote site are poorly understood, but
cannot be disregarded. Any such negative impacts have not
been modelled in our study.
In order to isolate the effects of alternative strategies we
have generally assumed all hospitals will perform equally
well, but in our model we found a doubling of clinical
benefit if thrombolysis rates across England were increased
from the current rates to a target of 20%. Though this study
focusses on modelling alternative strategies for where
emergency stroke patients should go, it should not be
forgotten that identifying the causes of poor performance
and delays at individual hospitals remains important.55,56
Study limitations
We have not directly modelled stroke mimics. Mimics may
be identified at different stages of the pathway, by para-
medics, in the emergency department, or after admission to
a stroke unit. Published data for this latter category would
suggest a rule of up to ‘one third again’ for mimics.57,58
While mimics should have little or no effect on the number
of IVT and MT procedures, they will affect total ambulance
conveyance numbers, and caseloads for emergency de-
partments and stroke teams. Any changes to hospital des-
tination with different emergency stroke strategies are likely
to be amplified by the presence of stroke mimics.
We have modelled and presented clinical benefit purely
in terms of disability-free survival, rather than reductions in
other disability states. For instance, converting a patient
from severe disability (mRS 4–5) to mild disability (mRS 2)
is a significant gain and even reduction from severe to
moderate disability (mRS 3) is advantageous to individuals
and society. We have defined mRS 0–1 rather than 0–2 as a
good outcome, whereas mRS 0–1 is in reality an excellent
outcome; our modelling therefore presents a conservative
picture of the population benefit from the widespread ap-
plication of reperfusion treatments.
Our estimates of the time-dependent benefits of MT are
based on the largest completed study of the effectiveness of
MT in a national acute stroke system, the Dutch MR
CLEAN randomised controlled trial.59 We used these data,
in preference to the HERMES individual patient meta-
analysis,60 on the understanding that MR CLEAN most
closely represents the implementation of MT within the
English NHS. The HERMES meta-analysis included several
studies which used imaging-based selection of later-
presenting patients, which has the effect of flattening the
curve representing the decay of absolute benefit fromMTover
time.61 Currently this category of late-presenting patients
represents very few patients treated in England, but as clinical
practice develops with patients who are late-presenting orwho
have unknown onset time, this is likely to involve more MT-
eligible, IVT-ineligible patients, and thus strengthen the case
for a predominantly mothership model.
We have modelled only England in our study. While
many of the principles (e.g. the advantages of direct transfer
to MTexcept when travel times to MTare very long, and the
potential destabilising effect of bypass for some patients
away from their local IVT-only centre) will be applicable in
many countries, the results presented pertain particularly to
England. Separate modelling for other countries should be
undertaken when planning services.
Conclusions
Our study has used outcome-based modelling to compare the
two principal service configurations for the wider availability
of MT in the UK – drip-and-ship or mothership – and it has
identified large potential reductions in population disability
from greater access to reperfusion therapy. However, deliv-
ering these gains within a constrained system demands a
balance between diverting excessive patient numbers to MT-
capable sites and depleting IVT-only sites of activity and
expertise. Current methods of patient selection including pre-
hospital clinical diagnostic tests and bypass policies may de-
stabilise such systems and at present do not offer methods that
are sufficiently reliable to justify widespread adoption. Further
research is needed to identify the best combination of pre-
hospital selection and divert policies that confers the greatest
population benefit within a sustainable acute care system.
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